IL-3 maintains activation of the p90S6K/RPS6 pathway and increases translation in human eosinophils

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2529-2539

  Esnault, Stephane ^a   Kelly, Elizabeth A B ^a   Shen, Zhong Jian ^b   Johansson, Mats W ^a   Malter, James S ^b   Jarjour, Nizar N ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; S6 KINASE; SEMAPHORIN; SEMAPHORIN 7A; UNCLASSIFIED DRUG; IL3 PROTEIN, HUMAN; IL5 PROTEIN, HUMAN; IL5RA PROTEIN, HUMAN; INTERLEUKIN 5 RECEPTOR ALPHA; MESSENGER RNA; PROTEIN S6;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; EOSINOPHIL; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANTAGONISTS AND INHIBITORS; ASTHMA; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; EOSINOPHILIA; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ASTHMA; CELLS, CULTURED; ENZYME ACTIVATION; EOSINOPHILIA; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-3; INTERLEUKIN-5; INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES; RNA, MESSENGER; SEMAPHORINS; SIGNAL TRANSDUCTION;

EID: 84941754194     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500871     Document Type: Article

References (62)

1. Esnault, S., E. A. Kelly, L. M. Nettenstrom, E. B. Cook, C. M. Seroogy, and N. N. Jarjour. 2012. Human eosinophils release IL-1 and increase expression of IL-17A in activated CD4+ T lymphocytes. Clin. Exp. Allergy 42: 1756-1764.
2. Travers, J., and M. E. Rothenberg. 2015. Eosinophils in mucosal immune responses. Mucosal Immunol. 8: 464-475.
3. Broekema, M., F. Volbeda, W. Timens, A. Dijkstra, N. A. Lee, J. J. Lee, M. E. Lodewijk, D. S. Postma, M. N. Hylkema, and N. H. ten Hacken. 2010. Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1). Respir. Med. 104: 1254-1262.
4. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E.McKenna, S. Ghiran, N. P. Gerard, C. Yu, S.H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776-1779.
5. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776.
6. Hilvering, B., L. Xue, and I. D. Pavord. 2015. Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma. Ther. Adv. Respir. Dis. 9: 135-145 .
7. Flood-Page, P. T., A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson. 2003. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 167: 199-204.
8. Haldar, P., C. E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, R. P. Marshall, P. Bradding, R. H. Green, A. J. Wardlaw, and I. D. Pavord. 2009. Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 360: 973-984.
9. Nair, P., M. M. Pizzichini, M. Kjarsgaard, M. D. Inman, A. Efthimiadis, E. Pizzichini, F. E. Hargreave, and P. M. O'Byrne. 2009. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med. 360: 985-993.
10. Flood-Page, P., C. Swenson, I. Faiferman, J. Matthews, M. Williams, L. Brannick, D. Robinson, S. Wenzel, W. Busse, T. T. Hansel, and N. C. Barnes, International Mepolizumab Study Group. 2007. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am. J. Respir. Crit. Care Med. 176: 1062-1071.
11. Liu, L. Y., J. B. Sedgwick, M. E. Bates, R. F. Vrtis, J. E. Gern, H. Kita, N. N. Jarjour, W. W. Busse, and E. A. B. Kelly. 2002. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J. Immunol. 169: 6452-6458.
12. Johansson, M. W., K. A. Gunderson, E. A. Kelly, L. C. Denlinger, N. N. Jarjour, and D. F. Mosher. 2013. Anti-IL-5 attenuates activation and surface density of b(2)-integrins on circulating eosinophils after segmental antigen challenge. Clin. Exp. Allergy 43: 292-303.
13. Kelly, E. A., L. Y. Liu, S. Esnault, B. H. Quinchia Johnson, and N. N. Jarjour. 2012. Potent synergistic effect of IL-3 and TNF on matrix metalloproteinase 9 generation by human eosinophils. Cytokine 58: 199-206.
14. Esnault, S., E. A. Kelly, M. W. Johansson, L. Y. Liu, S. T. Han, M. Akhtar, N. Sandbo, D. F. Mosher, L. C. Denlinger, S. K. Mathur, et al. 2014. Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokines. Clin. Immunol. 150: 90-100.
15. Munitz, A., I. Bachelet, R. Eliashar, M. Khodoun, F. D. Finkelman, M. E. Rothenberg, and F. Levi-Schaffer. 2006. CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J. Immunol. 177: 77-83.
16. Schroeder, J. T., K. L. Chichester, and A. P. Bieneman. 2009. Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J. Immunol. 182: 2432-2438.
17. Johnsson, M., M. Bove, H. Bergquist, M. Olsson, S. Fornwall, K. Hassel, A. E. Wold, and C. Wenneras. 2011. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. J. Innate Immun. 3: 594-604.
18. Patil, S. P., J. P. Wisnivesky, P. J. Busse, E. A. Halm, and X. M. Li. 2011. Detection of immunological biomarkers correlated with asthma control and quality of life measurements in sera from chronic asthmatic patients. Ann. Allergy Asthma Immunol. 106: 205-213.
19. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92: 397-403.
20. Johansson, M. W., E. A. Kelly, W. W. Busse, N. N. Jarjour, and D. F. Mosher. 2008. Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge. J. Immunol. 180: 7622-7635.
21. Thomas, G., J. Martin-Pérez, M. Siegmann, and A. M. Otto. 1982. The effect of serum, EGF, PGF2 alpha and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis. Cell 30: 235-242.
22. Evans, S. W., and W. L. Farrar. 1987. Interleukin 2 and diacylglycerol stimulate phosphorylation of 40 S ribosomal S6 protein. Correlation with increased protein synthesis and S6 kinase activation. J. Biol. Chem. 262: 4624-4630.
23. Chung, J., C. J. Kuo, G. R. Crabtree, and J. Blenis. 1992. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69: 1227-1236.
24. Ruvinsky, I., N. Sharon, T. Lerer, H. Cohen, M. Stolovich-Rain, T. Nir, Y. Dor, P. Zisman, and O. Meyuhas. 2005. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19: 2199-2211.
25. Duncan, R., and E. H. McConkey. 1982. Preferential utilization of phosphorylated 40-S ribosomal subunits during initiation complex formation. Eur. J. Biochem. 123: 535-538.
26. Nygard, O., and H. Nika. 1982. Identification by RNA-protein cross-linking of ribosomal proteins located at the interface between the small and the large subunits of mammalian ribosomes. EMBO J. 1: 357-362.
27. Bandi, H. R., S. Ferrari, J. Krieg, H. E. Meyer, and G. Thomas. 1993. Identification of 40 S ribosomal protein S6 phosphorylation sites in Swiss mouse 3T3 fibroblasts stimulated with serum. J. Biol. Chem. 268: 4530-4533.
28. Khalaileh, A., A. Dreazen, A. Khatib, R. Apel, A. Swisa, N. Kidess-Bassir, A. Maitra, O. Meyuhas, Y. Dor, and G. Zamir. 2013. Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. Cancer Res. 73: 1811-1820.
29. Kelly, E. A., R. R. Rodriguez, W. W. Busse, and N. N. Jarjour. 1997. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am. J. Respir. Crit. Care Med. 156: 1421-1428.
30. Dunn, K. W., M. M. Kamocka, and J. H. McDonald. 2011. A practical guide to evaluating colocalization in biological microscopy. Am. J. Physiol. Cell Physiol. 300: C723-C742.
31. Liu, L. Y., J. B. Sedgwick, M. E. Bates, R. F. Vrtis, J. E. Gern, H. Kita, N. N. Jarjour, W. W. Busse, and E. A. Kelly. 2002. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process. J. Immunol. 169: 6459-6466.
32. Roux, P. P., D. Shahbazian, H. Vu, M. K. Holz, M. S. Cohen, J. Taunton, N. Sonenberg, and J. Blenis. 2007. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J. Biol. Chem. 282: 14056-14064.
33. Erikson, E., and J. L. Maller. 1985. A protein kinase from Xenopus eggs specific for ribosomal protein S6. Proc. Natl. Acad. Sci. USA 82: 742-746.
34. Chen, R. H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol. Cell. Biol. 12: 915-927.
35. Zaru, R., N. Ronkina, M. Gaestel, J. S. Arthur, and C. Watts. 2007. The MAPKactivated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat. Immunol. 8: 1227-1235.
36. Shahbazian, D., P. P. Roux, V. Mieulet, M. S. Cohen, B. Raught, J. Taunton, J. W. Hershey, J. Blenis, M. Pende, and N. Sonenberg. 2006. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25: 2781-2791.
37. Meyuhas, O. 2008. Physiological roles of ribosomal protein S6: one of its kind. Int. Rev. Cell Mol. Biol. 268: 1-37.
38. Chauvin, C., V. Koka, A. Nouschi, V. Mieulet, C. Hoareau-Aveilla, A. Dreazen, N. Cagnard, W. Carpentier, T. Kiss, O. Meyuhas, and M. Pende. 2014. Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program. Oncogene 33: 474-483.
39. Shen, Z. J., S. Esnault, L. A. Rosenthal, R. J. Szakaly, R. L. Sorkness, P. R. Westmark, M. Sandor, and J. S. Malter. 2008. Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J. Clin. Invest. 118: 479-490.
40. Chiang, C. W., G. Harris, C. Ellig, S. C. Masters, R. Subramanian, S. Shenolikar, B. E. Wadzinski, and E. Yang. 2001. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 97: 1289-1297.
41. Hutchinson, J. A., N. P. Shanware, H. Chang, and R. S. Tibbetts. 2011. Regulation of ribosomal protein S6 phosphorylation by casein kinase 1 and protein phosphatase 1. J. Biol. Chem. 286: 8688-8696.
42. Erikson, E., and J. L. Maller. 1988. Substrate specificity of ribosomal protein S6 kinase II from Xenopus eggs. Second Messengers Phosphoproteins 12: 135-143.
43. Lara, R., M. J. Seckl, and O. E. Pardo. 2013. The p90 RSK family members: common functions and isoform specificity. Cancer Res. 73: 5301-5308.
44. Angenstein, F., W. T. Greenough, and I. J. Weiler. 1998. Metabotropic glutamate receptor-initiated translocation of protein kinase p90rsk to polyribosomes: a possible factor regulating synaptic protein synthesis. Proc. Natl. Acad. Sci. USA 95: 15078-15083.
45. Jensen, C. J., M. B. Buch, T. O. Krag, B. A. Hemmings, S. Gammeltoft, and M. Frödin. 1999. 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J. Biol. Chem. 274: 27168-27176.
46. Gregory, B., A. Kirchem, S. Phipps, P. Gevaert, C. Pridgeon, S. M. Rankin, and D. S. Robinson. 2003. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GMCSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. J. Immunol. 170: 5359-5366.
47. Noon-Song, E. N., C. M. Ahmed, R. Dabelic, J. Canton, and H. M. Johnson. 2011. Controlling nuclear JAKs and STATs for specific gene activation by IFNg. Biochem. Biophys. Res. Commun. 410: 648-653.
48. Jans, D. A., L. J. Briggs, S. E. Gustin, P. Jans, S. Ford, and I. G. Young. 1997. The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro. FEBS Lett. 410: 368-372.
49. Munitz, A., I. Bachelet, R. Eliashar, A. Moretta, L. Moretta, and F. Levi-Schaffer. 2006. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 107: 1996-2003.
50. Cloutier, A., T. Ear, E. Blais-Charron, C. M. Dubois, and P. P. McDonald. 2007. Differential involvement of NF-kappaB and MAP kinase pathways in the generation of inflammatory cytokines by human neutrophils. J. Leukoc. Biol. 81: 567-577.
51. Thomas, G. 2000. An encore for ribosome biogenesis in the control of cell proliferation. Nat. Cell Biol. 2: E71-E72.
52. Thomas, G., G. Thomas, and H. Luther. 1981. Transcriptional and translational control of cytoplasmic proteins after serum stimulation of quiescent Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 78: 5712-5716.
53. Mazumder, B., P. Sampath, V. Seshadri, R. K. Maitra, P. E. DiCorleto, and P. L. Fox. 2003. Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell 115: 187-198.
54. Takagi, M., M. J. Absalon, K. G. McLure, and M. B. Kastan. 2005. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123: 49-63.
55. Jefferies, H. B., C. Reinhard, S. C. Kozma, and G. Thomas. 1994. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. USA 91: 4441-4445.
56. Holz, M. K., B. A. Ballif, S. P. Gygi, and J. Blenis. 2005. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123: 569-580.
57. Frödin, M., and S. Gammeltoft. 1999. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151: 65-77.
58. De Minicis, S., C. Rychlicki, L. Agostinelli, S. Saccomanno, L. Trozzi, C. Candelaresi, R. Bataller, C. Millán, D. A. Brenner, M. Vivarelli, et al. 2013. Semaphorin 7A contributes to TGF-b-mediated liver fibrogenesis. Am. J. Pathol. 183: 820-830.
59. Kang, H. R., C. G. Lee, R. J. Homer, and J. A. Elias. 2007. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis. J. Exp. Med. 204: 1083-1093.
60. Tamagnone, L., S. Artigiani, H. Chen, Z. He, G. I. Ming, H. Song, A. Chedotal, M. L.Winberg, C. S. Goodman, M. Poo, et al. 1999. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80.
61. Granja, T., D. Köhler, V. Mirakaj, E. Nelson, K. König, and P. Rosenberger. 2014. Crucial role of Plexin C1 for pulmonary inflammation and survival during lung injury. Mucosal Immunol. 7: 879-891.
62. Davoine, F., and P. Lacy. 2014. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front. Immunol. 5: 570.